ERBB2 and Paget disease: From the data reported by Wu et al. [2], the largest study of recurrent Paget’s disease, we found that the immunochemical characteristics did not change in recurrent tumors compared with primary tumors that expressed ER/PR-negativity and HER-2 positivity.